Johnson & Johnson (JNJ) Comparison with companies in other sectors?

Johnson & Johnson has a share price of 2.41B. You can analyze Johnson & Johnson (JNJ) competitors across different market sectors through stock heatmaps.

What are JNJ's NET and operating margins?

Johnson & Johnson (JNJ) operating margin is around 0.24, and net profit margin is approximately 0.25 as of the latest reports.

In what way does JNJ's earnings per share (EPS) trend reflect its financial momentum?

Johnson & Johnson (JNJ) EPS is 9.34 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Johnson & Johnson is 18.02, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Johnson & Johnson?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Johnson & Johnson like P/E which is 17.96, P/B which is 5.19, and PEG which is 4.79. Compare them with sector averages to evaluate if the stock is priced fairly.

Johnson & Johnson

JNJ•NYSE

Healthcare

Drug Manufacturers - General

$168.30

$-1.26(-0.74%)

Fundamental Analysis of Johnson & Johnson (JNJ)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$9.34

P/E Ratio

18.02

ROE

0.30%

Net Margin

0.25%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$405.04B

Shares OutstandingTotal number of shares issued

$2.41B

Book Value/ShareNet worth per share

$32.44

Revenue/ShareAnnual revenue per share

$37.46

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$9.34

Net MarginNet income as percentage of revenue

25.005%

Operating MarginOperating income as percentage of revenue

24.42%

ROEReturn on shareholders' equity

30.39%

ROAReturn on total assets

11.72%

ROCEReturn on capital employed

15.90%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$6.93

Cash/ShareCash and equivalents per share

$7.80

FCF YieldFree cash flow as percentage of market cap

4.14%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

$5.02

Dividend YieldAnnual dividend as percentage of stock price

2.98%

Financial Ratios Analysis data is not available for JNJFinancial Ratios Analysis details for JNJ are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for JNJSector Benchmarking details for JNJ are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Johnson & Johnson Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Johnson & Johnson. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Johnson & Johnson's unique business strengths and challenges.

Key Financial Metrics for Johnson & Johnson

For Johnson & Johnson, essential financial indicators include EPS 9.34, PE 18.02, and ROE 0.30. These key ratios reveal insights into Johnson & Johnson's profitability, valuation, and operational health. Understanding these metrics enables you to compare Johnson & Johnson with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Johnson & Johnson

Metrics like Net Margin 25.005% and ROA 11.72% shed light on how well Johnson & Johnson is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Johnson & Johnson can sustain its operations and continue growing in the future.

Valuation and Market Position of Johnson & Johnson

Using ratios such as P/B Ratio 5.19 and PEG Ratio 4.79, investors can assess whether Johnson & Johnson is appropriately valued based on its financials and growth potential. These figures, combined with Johnson & Johnson's market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Johnson & Johnson

Financial health indicators, such as Debt/Equity Ratio 0.15 and Cash Flow $6.93, provide a snapshot of Johnson & Johnson's ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Johnson & Johnson, is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Johnson & Johnson

Investing in Johnson & Johnson based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Johnson & Johnson focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;